VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today shared results from the ...
Every day, millions of people in the U.S. live with dry eye. Some may feel a slight scratchiness now and then, while others may experience constant burning, grittiness, itching and discomfort. Above ...
Dry eyes can cause significant discomfort, and the symptoms become more common as we age. However, until now, it was unclear what proportion of the population suffered from the condition, with ...
Being an Oculoplastic and facial aesthetics surgeon, I frequently come across patients who present with persistent discomfort in their eyes, which causes burning, irritation, and even blurred vision.
Please provide your email address to receive an email when new articles are posted on . INDIANAPOLIS — The oral supplement NutriTears significantly improved dry eye symptoms and tear volume compared ...
Dry eye disease is a condition that occurs when your eyes do not make enough tears or when your tears dry up too quickly. Tears are essential for keeping the surface of your eyes healthy, comfortable, ...
If you have dry eye, you know how uncomfortable it can be. Dry eye disease happens when your eyes do not make enough quality tears or when your tears dry out too quickly. This can lead to eye ...
When dry eye inflammation occurs, it can develop into a painful cycle. But there are measures that can help prevent and treat it. The number of people experiencing dry eye inflammation is higher than ...
Please provide your email address to receive an email when new articles are posted on . INDIANAPOLIS — Progression of ocular surface disease appears significant among young adults, including those who ...
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
MFDS IND approval enables a multicenter, randomized, double-blind, vehicle-controlled phase 2 study in ~150 DED patients, randomized 1:1:1 to two dosing arms versus control over 12 weeks. Prior phase ...